Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed, 1 Injured in Crash on Highway 165


2 Honda Civics Collide Head-on in Fatal Los Banos Accident

Fatal Accident 6

Los Banos, CA (October 7, 2019) – One person was killed and another was injured in a head-on crash in Los Banos. The fatal accident occurred on the morning of October 7 on Highway 165.

Two Honda Civics collided head-on when the southbound vehicle crossed the center line of Highway 165, a two-lane rural highway. The male driver of the northbound vehicle died at the accident scene. The driver of the southbound vehicle, a 25-year-old man from Keyes, was airlifted to a local hospital with major injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Banos

#93635


May 25, 2020

Bicyclist Killed in Crash on Auberry Road

Motorcycle, Bicycle Collide in Fatal Clovis Accident...


October 25, 2019

Man Killed in Crash on Lakeville Street

Big Rig Hits Man Riding Large Tricycle in Fatal Petaluma Accident Petaluma, CA ...


December 11, 2019

Man Killed in Crash on Marsh Drive

Suzuki Rear-Ends Parked Trailer in Fatal Pacheco Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.